Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15681313 | 0.81 | GAA (0.41) | GAAL3MBTL1 | |
| SCHEMBL19758091 | 0.80 | GAA (0.44) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL4443628 | 0.80 | GAA (0.44) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL4958463 | 0.78 | GAA (0.43) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL13979303 | 0.78 | GAA (0.39) | GAAL3MBTL1KDM4E | |
| SCHEMBL10135305 | 0.77 | — | — | |
| SCHEMBL23355264 | 0.76 | GAA (0.41) | GAAL3MBTL1KDM4E | |
| SCHEMBL16710265 | 0.76 | GAA (0.41) | GAAL3MBTL1 | |
| SCHEMBL23326466 | 0.76 | GAA (0.41) | GAAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL4436204 | 0.76 | GAA (0.41) | GAAL3MBTL1KDM4EALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230402605-A1 | ELECTROCHEMICAL BATTERY WITH A BIPOLAR ARCHITECTURE COMPRISING A MATERIAL COMMON TO ALL OF THE ELECTRODES AS ELECTRODE ACTIVE MATERIAL | COMMISSARIAT À L'ENERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (FR) | 2023-12-14 | — | — | US | disclosed |
| EP-3588634-B1 | IMPROVED ORGANIC ELECTRODE MATERIAL | INNOVATIONLAB GMBH (DE) | 2023-11-22 | — | — | EP | disclosed |
| US-20230253563-A1 | ELECTROACTIVE MATERIALS FOR SECONDARY BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2023-08-10 | — | — | US | disclosed |
| EP-3049419-B1 | NOVEL 20(S)-SULFONYLAMIDINE DERIVATIVES OF CAMPTOTHECIN AND THE USE THEREOF AS A POTENT ANTITUMOR AGENT | UNIV MEDICAL HOSPITAL CHINA (TW) | 2017-11-08 | — | — | EP | disclosed |
| US-9765169-B2 | Functionalized polymer hybrids | CARNEGIE MELLON UNIVERSITY (US) | 2017-09-19 | — | — | US | disclosed |
| US-9718835-B2 | 20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent | CHINA MEDICAL UNIVERSITY HOSPITAL (TW) | 2017-08-01 | — | — | US | disclosed |
| US-20170095445-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES OF THE LUNG | RADIKAL THERAPEUTICS INC (US) | 2017-04-06 | — | — | US | disclosed |
| US-20160229862-A1 | NOVEL 20(S)-SULFONYLAMIDINE DERIVATIVES OF CAMPTOTHECIN AND THE USE THEREOF AS A POTENT ANTITUMOR AGENT | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2016-08-11 | — | — | US | disclosed |
| WO-2016007921-A1 | TREATING ARRHYTHMIA WITH MITOCHONDRIAL-TARGETED ANTIOXIDANTS | RHODEL ISLAND HOSPITAL (US) | 2016-01-14 | — | — | WO | disclosed |
| US-9099141-B2 | Radiation-curable vinyl chloride resin composition and magnetic recording medium using the same | FUJIFILM CORPORATION (JP) | 2015-08-04 | — | — | US | disclosed |
| US-20100056723-A1 | THERMOPLASTIC ELASTOMER COMPOSITION | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2010-03-04 | — | — | US | disclosed |
| US-7589155-B2 | Modified butyl rubber composition | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2009-09-15 | — | — | US | disclosed |
| US-20090156728-A1 | MODIFIED BUTYL RUBBER COMPOSITION | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20080305055-A1 | Anti-Radical Agents | CIBA CORPORATION | 2008-12-11 | — | — | US | disclosed |
| US-20080262147-A1 | Modified by a nitroxide-free radical stable in the presence of oxygen at an ordinary temperature (a 2,2,6,6-tetramethyl piperidinyloxy derivative) and an organic peroxide crosslinking agent; improved cost efficiency; high tensile properties | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| US-7282542-B2 | Modification method of polymer | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2007-10-16 | — | — | US | disclosed |
| US-20070093607-A1 | Modified butyl rubber composition | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1777237-A1 | Modified butyl rubber composition | The Yokohama Rubber Co., Ltd. (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-7196144-B2 | Process for modification of polymer | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2007-03-27 | — | — | US | disclosed |
| EP-1186588-A1 | 6-HYDROXY-2-NAPHTHYLCARBINOL AND PROCESS FOR THE PREPARATION THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170095445-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES OF THE LUNG | MPO, ELANE, CYSLTR2 | GAA 3976/4885L3MBTL1 997/4885KDM4E 4764/4885 |
| US-20080305055-A1 | Anti-Radical Agents | NOS3, GSTO1, PTGS1 | GAA 4532/4885L3MBTL1 1381/4885KDM4E 2996/4885 |
| US-20160229862-A1 | NOVEL 20(S)-SULFONYLAMIDINE DERIVATIVES OF CAMPTOTHECIN AND THE USE THEREOF AS A POTENT ANTITUMOR AGENT | BRDT, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, API5 | GAA 2359/4885L3MBTL1 1557/4885KDM4E 3930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.